{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-050654","form_type":"8-K","ticker":"MRK","cik":"0000310158","company_name":"Merck & Co., Inc.","filed_at":"2023-04-27T23:59:59+00:00","discovered_at":"2026-05-14T18:03:41.716611+00:00","generated_at":"2026-06-16T09:38:29.977231+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Merck Q1 revenue $14.5B (-9%), GAAP EPS $1.11; raises FY non-GAAP EPS guidance to $6.88-$7.00","bullets":["Q1 revenue $14.5B, down 9% YoY; excluding LAGEVRIO and FX, up 15%.","GAAP EPS $1.11, Non-GAAP EPS $1.40; both down 35% YoY.","KEYTRUDA sales $5.8B (+20%), GARDASIL sales $2.0B (+35% YoY).","LAGEVRIO sales fell 88% to $392M; proposed Prometheus acquisition for $10.8B expected Q3 2023.","FY2023 outlook raised: sales $57.7-$58.9B, Non-GAAP EPS $6.88-$7.00; GAAP EPS lowered to $5.85-$5.97 on Zetia settlement."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-050654","json":"https://secwatch.observer/filing/0001104659-23-050654.json","markdown":"https://secwatch.observer/filing/0001104659-23-050654.md","text":"https://secwatch.observer/filing/0001104659-23-050654.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/310158/000110465923050654/0001104659-23-050654-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/310158/000110465923050654/tm2313695d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-16T09:38:29.977231+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}